03/11/2026
In advanced medical device development, the way a material interacts with the human body is just as important as its mechanical performance. Degradable biomaterials are increasingly used in modern healthcare because they can provide temporary structural support, controlled drug delivery, and improved patient outcomes without requiring long-term implantation.
Two commonly discussed categories in this field are biodegradable and bioabsorbable materials. While these terms are often used interchangeably, they represent distinct biological processes that influence how a device behaves once implanted.
Biodegradable materials are designed to gradually break down through chemical or biological mechanisms such as hydrolysis or enzymatic activity. During this process, the material structure is reduced into smaller components over time, which may remain temporarily in the body or undergo further biological processing before elimination.
Bioabsorbable materials go one step further. In addition to degrading, they are fully absorbed and metabolized by the body, leaving no permanent residue behind. Their degradation byproducts are typically converted into natural metabolites and cleared through normal physiological pathways.
The selection between these materials plays a critical role in implant design, drug delivery systems, cardiovascular devices, orthopedic applications, and tissue engineering technologies. Factors such as degradation rate, mechanical strength, biocompatibility, and clinical function must all be carefully balanced to ensure optimal device performance and patient safety.
At Revive Medical Technologies Inc. our biomaterials research focuses on developing medical solutions that incorporate controlled degradation profiles, high biocompatibility, and predictable performance. By leveraging advanced biomaterials science, we aim to support the development of next-generation medical devices and drug delivery systems that align with modern regulatory and clinical requirements.
